Medy-Tox Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	251,076	247,290	228,622	221,121	195,096	184,870
Other Revenue	-	-	-	-	-0	-0
Revenue	251,076	247,290	228,622	221,121	195,096	184,870
Revenue Growth	7.01%	8.17%	3.39%	13.34%	5.53%	31.27%
Cost of Revenue	96,085	104,449	90,038	87,625	69,048	79,397
Gross Profit	154,990	142,841	138,584	133,496	126,048	105,473
Selling, General & Admin	100,529	88,723	78,370	86,605	47,679	41,938
Research & Development	29,190	29,190	29,821	25,133	23,324	23,267
Amortization of Goodwill & Intangibles	2,340	2,340	2,282	1,284	799.22	834.58
Other Operating Expenses	1,413	1,413	1,346	1,322	1,242	1,216
Operating Expenses	137,969	126,163	118,236	116,173	79,383	72,335
Operating Income	17,022	16,679	20,349	17,322	46,665	33,138
Interest Expense	-649.39	-649.39	-1,727	-2,333	-2,314	-4,781
Interest & Investment Income	1,395	1,395	925.15	896.43	610.76	957.22
Earnings From Equity Investments	-6,983	-7,314	5,877	1,363	5,129	-1,456
Currency Exchange Gain (Loss)	-325.57	-325.57	4,387	475.22	3,425	2,111
Other Non Operating Income (Expenses)	606.86	106.18	-4,138	-605.87	-715.84	108,431
EBT Excluding Unusual Items	11,066	9,891	25,673	17,118	52,800	138,400
Gain (Loss) on Sale of Investments	-4,378	-4,378	126.49	-593.36	-3,044	2,666
Gain (Loss) on Sale of Assets	305.61	305.61	323.58	-671.97	-230.42	131.48
Asset Writedown	764.94	764.94	-8,624	-	-	-12,932
Pretax Income	7,758	6,583	17,499	15,853	49,526	128,265
Income Tax Expense	-7,390	-9,076	1,425	6,163	12,930	35,003
Earnings From Continuing Operations	15,148	15,659	16,074	9,690	36,596	93,263
Minority Interest in Earnings	170.58	935.18	881.22	65.28	414.16	891.27
Net Income	15,319	16,594	16,955	9,755	37,010	94,154
Preferred Dividends & Other Adjustments	975	975	975	975	975.33	974.73
Net Income to Common	14,344	15,619	15,980	8,780	36,035	93,179
Net Income Growth	-21.26%	-2.26%	82.00%	-75.63%	-61.33%	-
Shares Outstanding (Basic)	6	7	7	7	7	6
Shares Outstanding (Diluted)	6	7	7	7	7	6
Shares Change	-0.03%	-2.03%	0.40%	2.02%	2.28%	0.04%
EPS (Basic)	2237.82	2371.01	2376.57	1311.06	5491.68	14587.59
EPS (Diluted)	2237.82	2371.01	2376.57	1311.00	5489.34	14517.37
EPS Growth	-21.24%	-0.23%	81.28%	-76.12%	-62.19%	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	54,395	45,749	27,830	5,862	16,304	2,452
Free Cash Flow Per Share	8486.24	6944.77	4138.95	875.31	2483.66	382.01
Gross Margin	61.73%	57.76%	60.62%	60.37%	64.61%	57.05%
Operating Margin	6.78%	6.74%	8.90%	7.83%	23.92%	17.93%
Profit Margin	5.71%	6.32%	6.99%	3.97%	18.47%	50.40%
Free Cash Flow Margin	21.66%	18.50%	12.17%	2.65%	8.36%	1.33%
EBITDA	37,142	36,745	40,307	32,698	61,766	51,394
EBITDA Margin	14.79%	14.86%	17.63%	14.79%	31.66%	27.80%
D&A For EBITDA	20,121	20,067	19,959	15,376	15,101	18,256
EBIT	17,022	16,679	20,349	17,322	46,665	33,138
EBIT Margin	6.78%	6.74%	8.90%	7.83%	23.92%	17.93%
Effective Tax Rate	-	-	8.15%	38.88%	26.11%	27.29%
Advertising Expenses	-	6,494	7,146	5,976	3,351	2,031